Respuesta inflamatoria y serologias positivas para Chlamidya pneumoniae Helicobacter pylori y citomegalovirus en personas con y sin factores de riesgo cardiovascular en Florencia, Caqueta

Campbell, Santiago; Quintero, Clara; Guevara, Narciso.
Acta méd. colomb ; 26(5): 221-230, sept.-oct. 2001. tab, graf
Artículo en Español | LILACS | ID: lil-358364

Documentos relacionados

  1. [Signs of microbial sensibilization in patients with various cardiovascular diseases].
  2. Gastric Epithelial Barrier Disruption, Inflammation and Oncogenic Signal Transduction by Helicobacter pylori.
  3. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
  4. Relationship between active Helicobacter pylori infection and risk factors of cardiovascular diseases, a cross-sectional hospital-based study in a Sub-Saharan setting.
  5. Helicobacter: Inflammation, immunology, and vaccines.
  6. Chlamydia pneumoniae inhibits activated human T lymphocyte proliferation by the induction of apoptotic and pyroptotic pathways.
  7. Pivotal Pathogenic and Biomarker Role of Chlamydia Pneumoniae in Neurovascular Diseases.
  8. Helicobacters and cancer, not only gastric cancer?
  9. Dietary Composition Influences Incidence of Helicobacter pylori-Induced Iron Deficiency Anemia and Gastric Ulceration.
  10. Infection and atherosclerosis: TLR-dependent pathways.